LifeBio Memory: Development of a Reminiscence Therapy Online Platform With Machine Learning to Increase Engagement

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorGeorge Mason University

About this trial

LifeBioMEMORY (LBM) is a reminiscence therapy (RT) mobile application that captures older adults' life stories in their own voices to promote social engagement and psychosocial well-being. This study will develop and evaluate an enhanced multilingual LBM app for community-dwelling, diverse older adults with mild cognitive impairment (MCI) or at risk of MCI and their informal caregivers, including Hispanic/Latino, Asian American (as one of subgroups, Korean), Black or African American, and non-Hispanic White populations. The app provides culturally tailored life story prompts with audio and visual cues to encourage reminiscence and storytelling. The intervention aims to improve quality of life, reduce depressive symptoms and loneliness, and strengthen caregiver-care recipient relationships, with the potential to provide an accessible, non-pharmacological approach to supporting cognitive and emotional well-being.

Eligibility criteria

Qualifiers

None

Disqualifiers

Self-identified as Hispanic/Latino, Korean, Black/African American, and Non-Hispanic White

Speak and read Spanish, Korean, or English

Aged 60 years and older, with Montreal Cognitive Assessment (MoCA) test scores ranging 18-30 (with MCI: 18-25, or at risk for MCI: 26-30)

Have a local or in-home informal caregiver who can participate who is age 18 or older

Trial design

Treatments tested in this trial

  • LifeBio Memory (LBM) digital reminiscence intervention

Treatment groups

168 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

George Mason University

Lead sponsor

National Institute on Aging (NIA)

Collaborator